HHS Proposed Rule Aligns Regulation on Confidentiality of Substance Use Disorder Treatment Records with HIPAA

by Kathie McDonald-McClure

UPDATE: On February 16, 2024, HHS published a Final Rule (89 Fed Reg 12472) to amend Part 2 rules on patient confidentiality of SUD records. While the Final Rule’s effective date is April 16, 2024, the deadline for compliance is February 16, 2026. Based on public comments to the Proposed Rule, HHS included further substantive modifications in the Final Rule, which HHS outlines in a Fact Sheet on the Part 2 Final Rule.

On November 28, 2022, the Secretary for the United States Department of Health & Human Services (HHS) released a Proposed Rule to amend the requirements in Title 42, Part 2, on confidentiality of substance use disorder (SUD) patient records in federally assisted Part 2 Programs.  Part 2 protects the confidentiality of SUD patient records (which generally include alcoholism, alcohol abuse, and drug abuse treatment and prevention records) by restricting the circumstances under which Part 2 Programs or other lawful holders can disclose such records.

Continue reading

The EPCS Mandate: Kentucky Requires Electronic Prescribing Of Controlled Substances

by Lindsay K. Scott

In an ongoing effort to battle the opioid crisis, Kentucky House Bill 342 was signed into law on March 26, 2019.  This bill created a new statute, KRS 218A.182, to require that all prescriptions for controlled substances be submitted electronically, unless certain exceptions apply (the “EPCS Mandate”).  Effective January 1, 2021, practitioners who prescribe controlled substances to be dispensed by a Kentucky pharmacy must issue the prescription electronically (“e-prescribe”) directly to the pharmacy unless an exception applies. Continue reading